The pharmaceutical firm making cystic fibrosis drug - Orkambi- says it's got EU approval to treat children.
Manufacturer Vertex says it'll now be suitable for use for those aged 6 to 11. It's already licensed for patients 12 and over. Earlier this year the HSE agreed to make Orkambi available to Irish patients after major price negotiations with the pharma industry.
Wexford Carer Honoured as 2026 Regional Carer of the Year
Oireachtas Committee to Visit Wexford Over Lady’s Island Lake Crisis
County Wexford Chamber Launches Major Drive to Promote Jobs, Investment and Innovation
Wexford Sees One of Lowest Rent Increases in the Country
